Preferred Label : Cardiac arrhythmia, ankyrin-b-related;
CISMeF acronym : LQT4;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Ankyrin-b syndrome;
Included titles and symbols : Long qt syndrome 4; LQT4;
Description : Loss-of-function mutations in ANK2 can result in a broad spectrum of clinical cardiac
phenotypes. Carriers of some mutations (e.g., E1425G, 106410.0001) display QT interval
prolongation, stress- and/or exercise-induced polymorphic ventricular arrhythmia,
syncope, and sudden cardiac death. Patients with other variants show clinical phenotypes,
sometimes mild, extending beyond LQTS, leading to the label 'ankyrin-B syndrome.'
These phenotypes include bradycardia, sinus arrhythmia, delayed conduction/conduction
block, idiopathic ventricular fibrillation, and catecholaminergic polymorphic ventricular
tachycardia (Mohler et al., 2007).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the ankyrin 2 gene (ANK2, 106410.0001);
Prefixed ID : #600919;
Origin ID : 600919;
UMLS CUI : C1970119;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)